Trase Secures $107M to Scale AI Across Care Delivery

Trase closed a $107M round to scale its AI-powered care-delivery platform. It is one of the largest healthcare AI checks of the summer, and part of a broader pattern where investors are backing operational AI in health systems more aggressively than consumer wellness plays.

What Trase does

Related: GPT-5 Is Here: Everything You Need to Know About OpenAI's Most Powerful Model Yet →

Trase's platform sits between EHR systems and clinical staff, using AI to automate documentation, care-plan drafting, and follow-up management for chronic-condition populations. The pitch is measurable ROI per clinician: hours saved per week, reduced no-show rates, better adherence outcomes.

Why this round is big

Related: Will AI Coding Agents Replace Developers? We Asked 100 Engineers →

$107M at this stage means Trase either has proven contracts with multiple health systems or a compelling growth curve inside the ones it has. Either way, it signals investor confidence that operational healthcare AI has crossed into meaningful revenue territory.

The category outlook

Related: The 27 Best AI Tools in 2026 (Tested for 90 Days) →

Care-delivery AI is one of the few AI categories where US health systems have real budget authority to buy, thanks to labor shortages and margin pressure. Expect more nine-figure rounds in this specific pocket over the rest of 2026.

The bottom line

Related: ChatGPT vs Claude 4: Which AI Should You Actually Pay For in 2026? →

Healthcare AI's investment story is quietly maturing around operations, not consumer apps. Trase's round is the latest confirmation.